DME Permits and Medical Device Distributor Licenses Are Not the Same

A DME permit and a medical-device distributor license serve different regulatory purposes. Understanding the distinction early can significantly affect distribution strategy, licensing requirements, geographic coverage, and the feasibility of a direct-to-patient business model.

Different Purpose. Different License.

A durable medical equipment permit is not simply another name for a medical-device distributor license. The two credentials may be issued by the same agency, but they can regulate different products, activities, facilities, and distribution channels.

A medical-device distributor license generally regulates the commercial movement of finished devices. A DME or home medical equipment permit is more commonly tied to supplying equipment to patients for use at home.

Its scope may depend on direct-to-patient delivery, rental, setup, maintenance, replacement, patient instruction, or emergency support—not merely on whether the product meets FDA’s definition of a medical device.

The Distribution Model Drives the License

The same product can produce different licensing outcomes. A distributor selling devices only to hospitals may fall within a wholesale-device regime but outside a DME regime.

Shipping qualifying equipment directly to patients, supporting continued home use, or billing a third-party payer may trigger a DME, homecare, pharmacy, or other state-specific requirement instead—or in addition to a medical-device distributor license.

Geography Can Determine Whether the Model Is Practical

DME regulation is often facility- and service-based. Some states require an in-state location or separately licensed service locations.

Others impose delivery, installation, maintenance, replacement, emergency-response, or patient-support obligations that effectively require the provider to operate within a practical service radius. Payer-enrollment rules may add further geographic restrictions.

For a manufacturer, this is not merely an application issue. A national direct-to-patient launch may require multiple local or regional distributors, a large national DME provider with an established service network, or substantial investment in the manufacturer’s own licensed facilities, personnel, inventory, and support infrastructure.

A manufacturer that could supply hospitals through one centrally located medical-device distributor may therefore be unable to use the same structure for a DME-regulated product.

The cost, complexity, and potential loss of direct commercial control may determine whether the product is launched nationally, introduced state by state, or supplied through an established DME network.

Home-State Credentials Create a Separate Question

Some states require a nonresident applicant to provide evidence of licensing and inspection in its resident state.

A DME permit may be accepted as the available home-state credential where that permit regulates the applicant’s facility and activities. It may be irrelevant where the company conducts only wholesale distribution or insufficient where the destination state expects a wholesale-device, legend-device, drug-distributor, pharmacy, or homecare credential.

This can create a circular dependency. A company may need a home-state DME permit before another state will accept its application, even though the home-state permit imposes operational requirements that do not fit the intended model.

Obtaining the credential solely to unlock other states may also create continuing obligations that were not anticipated.

Home Dialysis Illustrates the Problem

Peritoneal dialysis programs may involve equipment, disposable sets, accessories, dialysate, and prescription supplies delivered directly to a patient.

Those elements may fall under different state definitions and may be regulated through DME, pharmacy, legend-device, homecare, wholesale-distribution, or specialized dialysis provisions.

The analysis should therefore identify both the regulated product and the required service footprint: who owns, stores, sells, invoices, and ships the product; who delivers or installs it; what patient support is required; whether reimbursement is sought; and whether facilities or service capability must be maintained close to the patient.

Build Licensing and Patient Fulfillment Into One Strategy

MDD Options can assess the applicable state definitions, home-state dependencies, proximity requirements, and product-specific obligations before a manufacturer commits to a distribution structure.

Where DME rules make a centralized model impractical, MDD Options can help evaluate staged state entry, qualified regional providers, and its own Hybrid distribution model so that licensing, inventory control, patient fulfillment, and commercial oversight are addressed as one operating strategy.